These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36427777)

  • 61. Data science tools and applications on the way to Pharma 4.0.
    Steinwandter V; Borchert D; Herwig C
    Drug Discov Today; 2019 Sep; 24(9):1795-1805. PubMed ID: 31207205
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Entering the contract research industry in India.
    Joseph J
    Contemp Clin Trials; 2008 May; 29(3):311-3. PubMed ID: 18053773
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Big pharma wants you.
    Mack GS
    Nat Biotechnol; 2006 Nov; 24(11):1317-9. PubMed ID: 17162751
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.
    Carter AR; Meinert E; Brindley DA
    Rejuvenation Res; 2018 Aug; 21(4):291-293. PubMed ID: 30070166
    [No Abstract]   [Full Text] [Related]  

  • 65. The impact of unmanned stores' business models on sustainability.
    Denuwara N; Maijala J; Hakovirta M
    SN Bus Econ; 2021; 1(10):143. PubMed ID: 34778821
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Creating the ideal patient experience.
    Purcărea Th.V
    J Med Life; 2016; 9(4):380-385. PubMed ID: 27928442
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Partnership between small biotech and big pharma.
    Wiederrecht GJ; Hill RG; Beer MS
    IDrugs; 2006 Aug; 9(8):560-4. PubMed ID: 16871465
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Purchasers beware. Better oversight of foreign pharma plants just the first step.
    Alkire M
    Mod Healthc; 2009 Jun; 39(22):19. PubMed ID: 19522196
    [No Abstract]   [Full Text] [Related]  

  • 70. Blind-sided by privacy? Digital contact tracing, the Apple/Google API and big tech's newfound role as global health policy makers.
    Sharon T
    Ethics Inf Technol; 2021; 23(Suppl 1):45-57. PubMed ID: 32837287
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Take command of your growth.
    Treacy M; Sims J
    Harv Bus Rev; 2004 Apr; 82(4):127-33, 142. PubMed ID: 15077373
    [TBL] [Abstract][Full Text] [Related]  

  • 72. World Pharma Pricing and Market Access Congress - 11th Terrapinn Congress (March 19-20, 2019 - Amsterdam, the Netherlands).
    Barkan J
    Drugs Today (Barc); 2019 Apr; 55(4):287-290. PubMed ID: 31050696
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Getting the attention of Big Pharma. And Big Pharma is listening.
    Haugh R
    Hosp Health Netw; 2003 Oct; 77(10):44-8, 2. PubMed ID: 14595946
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharma giants to create databases on gifts to physicians.
    Kondro W
    CMAJ; 2008 Nov; 179(11):1118. PubMed ID: 19015561
    [No Abstract]   [Full Text] [Related]  

  • 75. Can regenerative medicine save Big Pharma’s business model from the patent cliff?
    Denoon A; Vollebregt E
    Regen Med; 2010 Sep; 5(5):687-90. PubMed ID: 20868323
    [No Abstract]   [Full Text] [Related]  

  • 76. The Effect of Big Data-Based Digital Payments on Household Healthcare Expenditure.
    Li C; Li D; He S; Sun S; Tian Y; Wang Z
    Front Public Health; 2022; 10():922574. PubMed ID: 35719624
    [TBL] [Abstract][Full Text] [Related]  

  • 77. BIGCHEM: Challenges and Opportunities for Big Data Analysis in Chemistry.
    Tetko IV; Engkvist O; Koch U; Reymond JL; Chen H
    Mol Inform; 2016 Dec; 35(11-12):615-621. PubMed ID: 27464907
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Business of Health: Business of Healthcare.
    Berry MD;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-76. PubMed ID: 28248462
    [No Abstract]   [Full Text] [Related]  

  • 79. The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success.
    Evens RP; Kaitin KI
    Clin Pharmacol Ther; 2014 May; 95(5):528-32. PubMed ID: 24448474
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Big pharma and big medicine in big trouble.
    Spence D
    BMJ; 2013 Nov; 347():f6900. PubMed ID: 24243980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.